Commentary : Combating COVID-19-associated mucormycosis with limited resources.

Kim, Usha; Kulkarni, Pooja; Saini, Pragya

Kim, Usha; Kulkarni, Pooja; Saini, Pragya.

Kim U; Department of Orbit, Oculoplasty, Ocular Oncology and Ocular Prosthesis, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Madurai, Tamil Nadu, India.
Kulkarni P; Department of Orbit, Oculoplasty, Ocular Oncology and Ocular Prosthesis, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Madurai, Tamil Nadu, India.
Saini P; Department of Orbit, Oculoplasty, Ocular Oncology and Ocular Prosthesis, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Madurai, Tamil Nadu, India.

Indian J Ophthalmol ; 70(6): 2169, 2022 06.

Article in English | MEDLINE | ID: covidwho-1875914

Subject(s)

COVID-19; Mucorales; Mucormycosis; Humans; Mucormycosis/diagnosis; Mucormycosis/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Mucorales / Mucormycosis Type of study: Diagnostic study Limits: Humans Language: English Journal: Indian J Ophthalmol Year: 2022 Document Type: Article Affiliation country: Ijo.IJO_1250_22

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google